![Pyxus](http://bantamvape.com/cdn/shop/t/33/assets/Pyxus_Wordmark_Blue_RGB.png?v=93955650962028920131696537199")
Bantam Receives Filing Letter from FDA
Bantam Vape moves forward to next step in PMTA process
In our most recent blog post, we announced the acceptance of our PMTA application by the U.S. Food and Drug Administration. We are now excited to share the latest development in our application’s journey—our application has formally been “filed” by the FDA.
In short, we’ve received a filing letter from the FDA letting us know that their preliminary review of our PMTA is complete.
From here, our application moves to the next step of the process and undergo a formal substantive review. In this next stage, the FDA will conduct an in-depth evaluation of the scientific studies and data we submitted with our PMTA.
Check out Bantam's official announcement on our filing letter here.
![Pyxus](http://bantamvape.com/cdn/shop/t/33/assets/Pyxus_2_Colour_RGB.png?v=103239019718436972931696537199")
Warning:
This product can expose you to chemicals including formaldehyde, which is known to the state of California to cause cancer, and nicotine, which is known
to the state of California to cause birth defects and other reproductive harm. For more information go to www.P65Warnings.ca.gov. Do not use this product if you are
pregnant or nursing, have heart or liver disease, high blood pressure, diabetes, or are allergic to nicotine or any of the other ingredients. If swallowed or used incorrectly,
or you become ill using this product, seek immediate medical attention. Very toxic in contact with skin or if swallowed. Consult a doctor before use. Keep out of reach of
children and pets. This product is not to be sold to or used by minors. This material and its container must be disposed of in a safe and responsible manner, considering the environment.
This product is not a smoking cessation product and has not been evaluated as such. The long-term effects of using this product have not been established.